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and cTSH concentrations below and above the RI, respectively. In
dogs with normal cTSH, rhTSH stimulation test was performed to
confirm the diagnosis. SCr was measured for diagnostic or check-
up purposes and SDMA was measured afterwards from surplus of
serum stored at 20°C. In HD such measurements where per-
formed at T0 after 15 to 112 days (median 64.5) of treatment (T1)
with levothyroxine (10–15 µg/kg q12 h PO). SDMA was measured
using a validated immunoassay (IDEXX SDMA test).HD had a
median age of 4 years (4–15), median body weight (BW) of 37.5 kg
(7.9–53), 7/14 were male (1 castrated) and 7/14 female (3 spayed).
There were no significant differences regarding signalment and BW
between HD and control group. Median SDMA concentrations (RI
<14 µg/dL) were 10 µg/dL (6–17), 13.5 µg/dL (7–20) and 10.5 µg/
dL (5–17) in healthy dogs, HD at T0 and T1, respectively. SDMA
concentrations were significantly higher in HD at T0 in comparison
with healthy dogs (P < 0.029) and HD at T1 (P < 0.031). Among
HD, 7/14 had SDMA above the RI at T0 and only 1/14 (7%) at T1.
At T0, 4/14 HD had SCr above the RI (>1.35 mg/dL). SCr concen-
tration was significantly higher in HD at T0 compared to HD at T1
(P < 0.0082), and in one dog SCr was above the RI at T1. No signif-
icant correlation was observed between SDMA and T4, and SDMA
and SCr in the HD at T0 and T1.
This study shows that in HD SDMA concentrations are fre-
quently above the RI at diagnosis and normalize after treatment.
The GFR modifications that are present in canine hypothyroidism
may be better detected with SDMA compared to SCr.
Disclosures: No disclosures to report.
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Numerous portable blood glucose meters (PBGMs) have been devel-
oped during the last decade, the majority of which is designed for
use in humans. Recently one glucometer (Gluco Calea, WellionVet;
GC) and one glucose-ketones meter (Belua, WellionVet; BE) have
been developed for use in veterinary medicine. The aims of this
study were to assess the accuracy and precision of these devices in
feline venous and capillary blood samples based on ISO 15197:2013
and to evaluate packed cell volume (PCV) interferences.
Samples were obtained from 29 non anemic cats (PCV 30–47%)
and 18 anemic cats (PCV<30%) divided into three glycemic
ranges: high (>140 mg/dL), medium (90–139 mg/dL), and low
(<90 mg/dL). Paired measurements of glucose and 3-az-hydroxy-
butyrate (3-HB) from capillary and venous blood samples were
determined using the two devices and compared with the results of
reference methods (enzymatic hexokinase and 3-HB-dehydrogen-
ase, respectively) obtained by an automated chemistry analyzer
(Beckman-Coulter AU480). Linear regression, Bland Altman plots
and the Parkes error grid analysis (EG) were used to assess the
accuracy. PCV interferences for glucose measurement were
assessed comparing the differences between PBGMs readings and
reference method values in anemic and non-anemic cats. To assess
within-run precision, glucose concentrations obtained from 14
samples, belonging to the three glycemic ranges, were measured 10
times within 10 minutes. Between-day precision was assessed by
testing each manufacturer’s glucose control solution over 10 con-
secutive days. P < 0.05 was considered significant.
Mean differences (mg/dL) between measurements of each
PBGM on capillary and venous blood and values measured by the
reference method were: GC 30.7  35.4, 35.6.2  40.5, BE
15.5  35.5 and 15.0  24.1 respectively. A positive significant
correlation between all paired samples was found for both devices
(r > 0.89). However neither PBGMs totally fulfilled ISO require-
ments, but 100% of glucose values measured on venous blood
using BE fell in zone A+B of EG. Within-run and between-day
precision were adequate. The effect of PCV was significant (higher
results with lower PCV) only for BE.
The correlations between capillary and venous 3-HB and refer-
ence 3-HB were r = 0.66 and r = 0.82 respectively. Mean differ-
ences between capillary and venous 3-HB and reference method
were 0.07 (1.15) and 0.30 (1.48) respectively; within-run
precision was adequate.
Our results show that GC is not sufficiently accurate while the
superior performances of BE supports its clinical use in cats.
Disclosures: Disclosures to report.
Devices and test strips were provided by manufacturers (Wel-
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Considerable variation has been reported in total cell counts and
concentration of biochemical markers due to variable recovery of
pulmonary epithelial lining fluid (PELF) in bronchoalveolar lavage
(BAL) fluid. A number of chronic respiratory conditions can be
difficult to diagnose definitively and accounting for dilution of
PELF may allow us to better differentiate respiratory disease. Dif-
ferentiation of various chronic respiratory diseases may be made
via analysis of BAL fluid using urea concentration of BAL relative
to blood urea concentration as a marker of dilution of PELF.
Assessment of cell counts after adjusting for dilution may allow
differentiation of the primary disease process in dogs presenting
with respiratory signs.
Client-owned dogs presenting for investigation of respiratory
disease were included. All dogs had a BAL performed and BAL
cell counts were corrected after using urea as a marker for dilution
and comparison of urea in blood to that of urea in BAL fluid. A
final diagnosis of respiratory disease was made after retrospective
analysis of all diagnostic investigations and response to treatment.
Seventy two BAL samples from a total of 48 dogs were ana-
lyzed and thirteen primary causes of respiratory disease identified
based on diagnostic investigation including BAL cell cytology and
treatment response. Respiratory diseases were also assigned to
inflammatory, non-infectious, infectious, upper respiratory tract or
respiratory neoplasia categories based on the disease diagnosed.
There was no statistical difference in the adjusted total cell counts
of BAL fluid (BALF) from dogs with different respiratory diseases
or disease groups. Mycoplasma spp had no effect on the total cell
count in dogs with chronic bronchitis.
This study suggests total cell counts of BAL fluid corrected for
dilution by urea concentration cannot be used to distinguish
between different respiratory diseases. A larger number of cases
and cross section of respiratory disease may further identify signifi-
cant differences in total and differential cell counts of various dif-
ferent diseases.
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